Search results

Found 1,514 pages
AUTHOR: Anna Smith

Results per page

10 20 50 100

Sort by

Relevance Date

1 Oct 2019:

Invokana bags FDA approval

The treatment has been approved to reduce the risk of hospitalisation for heart failure in certain patients with type II diabetes. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/invokana_bags_fda_approval_1311532

25 Mar 2020:

COVID-19: AstraZeneca to distribute masks as ASCO goes virtual

PHE has also been awarded $500,000 by the US FDA  to bolster the international response. - News - PharmaTimes

by Anna Smith|Anna Smith

https://www.pharmatimes.com/news/covid-19_astrazeneca_to_distribute_masks_as_asco_goes_virtual_1329991

6 Sep 2019:

LIVI partners with Boots

The NHS Long Term Plan states that all patients should have access to online and video consultations by 2021. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/livi_partners_with_boots_1300885

24 Oct 2019:

Cosentyx receives EU label update

The drug is the first and only fully-human biologic that directly inhibits interleukin-17A. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/cosentyx_receives_eu_label_update_1314409

12 Feb 2020:

NICE refuses Keytruda, Inlyta cancer combo

Despite evidence suggesting that the Keytruda combo would be welcomed by patients, NICE cites uncertainty around the long-term benefit. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/nice_refuses_keytruda,_inlyta_cancer_combo_1325454

26 Jul 2019:

CHMP recommends five new medicines

Stelara, Keytruda and Tecentriq were also among the extensions of therapeutic indication. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/chmp_recommends_five_new_medicines_1295351

18 Mar 2020:

COVID-19: Pfizer, Regeneron to develop candidates, but solution…

As the case count for COVID-19 (coronavirus) in the UK hits 1950, pharma companies continue to pitch in with their efforts. - News - PharmaTimes

by Anna Smith|Anna Smith

https://www.pharmatimes.com/news/covid-19_pfizer,_regeneron_to_develop_candidates,_but_solution_likely_to_be_a_year_away_1329471

7 Oct 2019:

Sensyne, MHRA form research collaboration

The collaboration will contribute to the development of methods to validate software algorithms used in digital health. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/sensyne,_mhra_form_research_collaboration_1312063

26 Feb 2019:

Lynparza successful in pancreatic cancer trial

AstraZeneca and MSD's Lynparza is the first PARP inhibitor to demonstrate a benefit in pancreatic cancer, having hit targets in the Phase III POLO trial. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/lynparza_successful_in_pancreatic_cancer_trial_1279414

5 Apr 2019:

Myriad, AstraZeneca and MSD expand collaboration

The expansion will use BRACAnalysis CDx to identify germline BRCA mutations. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/myriad,_astrazeneca_and_msd_expand_collaboration_1283621